• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number 5MAXACE132
Device Problems Collapse (1099); Material Separation (1562)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/12/2014
Event Type  malfunction  
Event Description
The patient was undergoing a thrombectomy procedure using a penumbra system 5max ace reperfusion catheter.During the procedure, the physician reported that the catheter collapsed during aspiration.Upon retrieval, the catheter separated.The physician used another catheter to complete the procedure and there was no reported adverse effect on the patient.
 
Manufacturer Narrative
Result: the 5maxace catheter is fractured at approximately 19.0 and 20.0 cm from the hub.The 3max catheter is stuck inside of the fractured 5maxace catheter.The 5max catheter is flattened approximately 17.0 cm from the hub.The flat portion is approximately 95.0 cm in length.Conclusion: the device was returned for analysis and has been evaluated.The complaint indicates that the 5maxace collapsed under aspiration and then separated.The complaint did not describe any damage to the 3max or 5max catheters.A collapse in the catheter lumen was not confirmed however, evaluation of the returned product revealed two fractures in the 5maxace catheter.The 3max catheter was returned lodged inside of the fractured 5maxace.The 5max catheter was flattened beginning 17.0 cm from the hub moving distally for a length of 95.0 cm.The flattening in the 5max catheter may have been due to handling error if the rhv was not loosened prior to attempting to remove the catheter.These aspiration catheters are designed to withstand maximum aspiration pressure with the aspiration pump and do not collapse under aspiration.The cause of this complaint cannot directly be determined.The evaluation of the returned devices is not consistent with the description of the complaint.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.This mdr is associated with mdr 3005168196-2014-00183 and 00184.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
1351 harbor bay parkway
alameda CA 94502
Manufacturer (Section G)
PENUMBRA, INC.
1351 harbor bay parkway
alameda CA 94502
Manufacturer Contact
kathleen kidd
1351 harbor bay parkway
alameda, CA 94502
5107483200
MDR Report Key3691325
MDR Text Key4256991
Report Number3005168196-2014-00178
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K090752
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Health Professional
Type of Report Initial
Report Date 02/18/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/20/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date07/31/2016
Device Catalogue Number5MAXACE132
Device Lot NumberF36594
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/04/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/18/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/08/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-